Results 231 to 240 of about 10,360,825 (347)
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Attractive and simple synthesis route from benzil to two different types of amino acid-derived imidazoles: first preliminary results. [PDF]
Ferrer A +6 more
europepmc +1 more source
Immunoreceptor Signaling [PDF]
openaire +2 more sources
Neuronal Reward and Decision Signals: From Theories to Data.
W. Schultz
semanticscholar +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Dynamic optimization of high-bandwidth multi-receiver signals for civil aircraft flight tests telemetry. [PDF]
Liu T, Zhao C.
europepmc +1 more source
Complex Wavelets for Shift Invariant Analysis and Filtering of Signals
N. Kingsbury
semanticscholar +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
LIGO Core-Collapse Supernova Detection Using Convolutional Neural Networks. [PDF]
Pan Z +3 more
europepmc +1 more source

